| Friday 4 April 2003 | ||
| Organizer | F. Silvestris (Bari, Italy) | |
Apoptosis in clinical medicine |
||
| Session I | The altered apoptosis as disease mechanism(s) | |
| Chairs | F. Dammacco (Bari, Italy) & F. Indiveri (Genova, Italy) | Abstract No. |
| 09.40 – 09.45 | Introduction F. Dammacco (Bari, Italy) |
|
| 09.45 – 10.10 | Apoptosis: effector mechanisms and their derangements G. Kroemer (Paris, France) |
|
| 10.10 – 10.30 | Physiological and pathological mechanisms of red cell production R. De Maria (Rome, Italy) |
|
| 10.30 – 10.50 | Abnormal plasma cell apoptosis and tumor progression in multiple myeloma F. Silvestris (Bari, Italy) |
|
| 10.50 – 11.00 | Discussion | |
| 11.00 – 11.15 | coffee break | |
| Session II | Molecular mechanisms of apoptosis derangements and clinical diseases | |
| Chairs | G. Ricevuti (Pavia, Italy) & F. Silvestris (Bari, Italy) | Abstract No. |
| 11.15 – 11.35 | Apoptosis induction by soluble HLA molecules in CD8+ T lymphocytes and natural killer cells F. Puppo (Genova, Italy) |
|
| 11.35 – 11.55 | Secretion of pro-apoptotic intron-4-retaining soluble HLA-G1 by human villous trophoblast P. Le Bouteiller (Toulouse, Paris) |
|
| 11.55 – 12.00 | Discussion | |
| 12.00 – 12.15 | Reduced post-infarction myocardial apoptosis in women: a clue to their different clinical course? G.G.L. Biondi-Zoccai, A. Abbate, R. Bussani, D. Camilot, Q. Parisi, A. Dobrina, and A. Baldi (Rome, Italy/Trieste, Italy/Naples, Italy) |
175 |
| 12.15 – 12.30 | Serum markers of apoptosis in dialysis patients G. Sypniewska, A. Stefanska, and J. Manitius (Bydgoszcz, Poland) |
177 |
| 12.30 – 12.45 | Bcl-2 regulation by targeting the RNA adenine-uridine rich element A. Bevilacqua, and A. Nicolin (Milan, Italy) |
178 |
| 12.45 – 13.00 | DNAse I behaves as a transcription factor which modulates FAS expression in human cells M. Oliveri, A. Daga, C. Lunardi, R. Millo, R. Navone, C. Bason and A. Puccetti (Genova/Verona, Italy) |
183 |
| 13.00 | End of workshop | |
Posters
179
FAS in Sepsis and organ failure in a rat model
U. Glatzel, R. Tolba, M. Tinelli, M. Lysson, A. Wentzensen, and T. Minor (Ludwigshafen/Bonn, Germany)
180
High-risk clinical features predict increased post-infarction myocardial apoptosis and the benefits due to an open infarct-related artery
A. Abbate, G.G.L. Biondi-Zoccai, R. Bussani, D. Camilot, A.M. Leone, Q. Parisi, F. Silvestri, A. Dobrina, and A. Baldi (Rome/Trieste/Naples, Italy)
182
T cell activation and enhanced apoptosis in non-ST elevation myocardial infarction patients
A.L. Pasqui, M. Di Renzo, G. Bova, F. Bruni, L. Puccetti, M. Pastorelli, G. Pompella, and A. Auteri (Siena, Italy)